Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a re-valuation of the cash element of the notional investment held in Ordinary Share ADRs within the US Retirement Savings Plan ("The Plan"), of GlaxoSmithKline plc, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned persons on 6 May 2011 of an increase in the notional allocation of Ordinary share ADRs on 5 May 2011 at a price of $42.87 per ADR:-
Director/PDMR
|
Number of Shares |
Connected Person |
Number of Shares |
||
Dr M M Slaoui |
9 |
Dr K Slaoui |
7 |
||
Mr W C Louv |
15 |
- |
- |
||
Dr D Pulman |
27 |
- |
- |
||
Mr E J Gray |
21 |
- |
- |
||
Ms D Connelly |
1 |
- |
- |
||
|
|
|
|||
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
6 May 2011